iCAD to Participate in The JMP Securities Life Sciences Conference And Piper Jaffray Heartland Summit
NASHUA, N.H. – June
18, 2019 – iCAD,
Inc. (NASDAQ: ICAD), a global
medical technology leader providing innovative cancer detection and therapy
solutions, today announced that Michael Klein, Chairman and Chief Executive
Officer, will present a corporate overview at the JMP Securities Life Sciences Conference
in New York, NY on Wednesday, June 19 at 12:00pm ET and will participate in the
Piper Jaffray Heartland Summit on Thursday, June 20 in Minneapolis, MN.
About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical
technology leader providing innovative cancer detection and therapy solutions.
For more information, visit www.icadmed.com.
Contact:
Media Inquiries:
Jessica Burns, iCAD, Inc. (623) 203-7270
or:
Investor Relations:
LifeSci Advisors, on behalf of iCAD, Inc.
Jeremy Feffer, (212) 915-2568